Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » research and development

research and development

Dec 10, 2020

Apis Assay Technologies, Moffitt Cancer Center to Evaluate RNA Biomarkers for Cancer Progression

The group aims to determine the feasibility of TROLL-2 and TROLL-3 as diagnostic biomarkers for the prediction of treatment efficacy and prognosis in breast cancer.

Dec 02, 2020

NanoString Technologies Reveals New High-Resolution Spatial Omics Platform Due 2022

Premium

The spatial molecular imager will be NanoString's next play in a growing market that it says is worth more than $12 billion, including diagnostic applications.

Nov 24, 2020

Startup Angstrom Bio Plans Saliva-Based COVID-19 Nucleic Acid Test on Nanopore Sequencing Platform

Premium

Angstrom Bio is developing a rapid, scalable coronavirus test that uses nanopore sequencing to detect barcoded PCR products.

Nov 23, 2020

Twist Bioscience Plots Continued Growth With NGS Product Push Into Ag-Bio, Cancer Dx

Premium

The firm is also pursuing advances in its manufacturing and ordering processes that it says will help it scale to $500 million in annual revenues.

Nov 17, 2020

NanoString Technologies, OHSU Partner on Breast Cancer Spatial Protein Profiling Assay Development

A new GeoMx Digital Spatial Profiler assay will have up to 30 protein targets and will be validated for potential use as a laboratory-developed test.

Nov 17, 2020

Italian Researchers Developing Plasmonic Biosensor for Colorectal Cancer Testing, Monitoring

Premium

The group is developing an ultrasensitive nanoparticle-enhanced plasmonic biosensor to detect RAS single nucleotide variants in plasma.

Nov 03, 2020

Pacific Biosciences Gears Up For Commercial, R&D Push With Eye Toward Collaborations

Premium

In their first conference call with investors, PacBio's new CEO and CFO laid out a strategic plan for the company as it weathers the COVID-19 pandemic.

Oct 29, 2020

Inflammatix Awarded $7.4M in Additional BARDA Funding for POC System, Acute Infection Test

The funding is part of a BARDA contract worth up to $72 million to support the development of a test to diagnose acute infection at the point of care.

Oct 14, 2020

10x Genomics Acquisitions Point Towards New In Situ Analyisis Platform

Premium

10x will develop a third genomics platform, possibly combining Cartana's more sensitive chemistry with ReadCoor's instrument.

Oct 08, 2020

Pacific Biosciences' New Sequel IIe System Puts Focus on High Read Accuracy

Premium

The single-molecule sequencing firm is skipping a beta testing program for its new sequencer, which should be available by the end of the year.

Pages

The Scan

Germany to Increase Viral Sequencing

Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.

Getting Used to It

23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.

Green Access at Science

The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.

Science Papers Examine Chronic Kidney Disease GWAS, Pneumonia Microbiome

In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.